Diagnosis of giant cell arteritis
- PMID: 32348512
- DOI: 10.1093/rheumatology/kez553
Diagnosis of giant cell arteritis
Abstract
GCA is the most common form of primary systemic vasculitis affecting older people. It is considered a clinical emergency because it can lead to irreversible blindness in around 20% of untreated cases. High doses of glucocorticoids should be initiated promptly to prevent disease-related complications; however, glucocorticoids therapy usually results in significant toxicity. Therefore, correct diagnosis is crucial. For many years, temporal artery biopsy has been considered the diagnostic 'gold standard' for GCA, but it has many limitations (including low sensitivity). US has proven to be effective for diagnosing GCA and can reliably replace temporal artery biopsy in particular clinical settings. In cases of suspected GCA with large-vessel involvement, other imaging modalities can be used for diagnosis (e.g. CT and PET). Here we review the current evidence for each diagnostic modality and propose an algorithm to diagnose cranial-GCA in a setting with rapid access to high quality US.
Keywords: computed tomography; diagnosis; giant cell arteritis; imaging; magnetic resonance; positron emission tomography; temporal artery biopsy; ultrasound.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Comment in
-
Comment on: Diagnosis of giant cell arteritis.Rheumatology (Oxford). 2020 Nov 1;59(11):e118. doi: 10.1093/rheumatology/keaa440. Rheumatology (Oxford). 2020. PMID: 32901271 No abstract available.
-
Comment on: Diagnosis of giant cell arteritis: reply.Rheumatology (Oxford). 2020 Nov 1;59(11):e119-e121. doi: 10.1093/rheumatology/keaa439. Rheumatology (Oxford). 2020. PMID: 32901272 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical